Two new potent neurotransmitter release enhancers, 10, 10-bis (4-pyridinylmethyl)-9 (10H)-anthracenone and 10, 10-bis (2-fluoro-4-pyridinylmethyl)-9 (10H) …

R Zaczek, RJ Chorvat, JA Saye… - … of Pharmacology and …, 1998 - ASPET
Linopirdine (3, 3-bis (4-pyridinylmethyl)-1-phenylindolin-2-one, DUP996) is an extensively
studied representative of a class of cognition enhancing compounds that increase the …

Diagnosis and management of Alzheimer's disease: past, present and future ethical issues

S Gauthier, A Leuzy, E Racine, P Rosa-Neto - Progress in neurobiology, 2013 - Elsevier
There is great interest in the ethical issues associated with Alzheimer's disease (AD) and
related dementias given the prevalence of AD and the evolving neuroscience landscape in …

Multitarget tacrine hybrids with neuroprotective properties to confront Alzheimer's disease

K Spilovska, J Korabecny… - Current Topics in …, 2017 - ingentaconnect.com
Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder. Several hallmarks
such as β-amyloid (Aβ) aggregation underlying amyloid plaque formation, Τ …

Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease

RS Doody, JK Dunn, CM Clark, M Farlow… - Dementia and geriatric …, 2001 - karger.com
Objective: To compare rates of cognitive decline between probable Alzheimer's disease
(AD) patients treated with long-duration cholinesterase inhibitors (ChE-Is) and those who …

Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting

VV Jogani, PJ Shah, P Mishra, AK Mishra… - Alzheimer Disease & …, 2008 - journals.lww.com
The aim of the investigation was to prepare and characterize microemulsion/mucoadhesive
microemulsion of tacrine (TME/TMME), assess its pharmacokinetic and pharmacodynamic …

Copy number variants in pharmacogenetic genes

Y He, JM Hoskins, HL McLeod - Trends in molecular medicine, 2011 - cell.com
Variation in drug efficacy and toxicity remains an important clinical concern. Presently, single
nucleotide polymorphisms (SNPs) only explain a portion of this problem, even in situations …

[HTML][HTML] Scoring systems for the Clock Drawing Test: A historical review

B Spenciere, H Alves… - Dementia & …, 2017 - SciELO Brasil
ABSTRACT The Clock Drawing Test (CDT) is a simple neuropsychological screening
instrument that is well accepted by patients and has solid psychometric properties. Several …

A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease

G Weyer, RM Babej-Dölle, D Hadler, S Hofmann… - …, 1997 - karger.com
Two doses of idebenone were studied in a prospective, randomized, double-blind, placebo-
controlled multicentre study in patients suffering from dementia of the Alzheimer type (DAT) …

Tacrine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease

AJ Wagstaff, D McTavish - Drugs & aging, 1994 - Springer
Synopsis Tacrine is a centrally acting cholinesterase inhibitor with additional
pharmacological activity on monoamine levels and ion channels. It has been postulated that …

[图书][B] Clinical diagnosis and management of Alzheimer's disease

S Gauthier - 2006 - books.google.com
The third edition of this successful textbook has been completely updated throughout and
includes new chapters on electrophysiological tests, biological markers, global staging …